Synapse - Cristina Antonescu

Results (908)

Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data

Journal Article

Wang, L.; Motoi, T.; Khanin, R.; Olshen, A.; Mertens, F.; Bridge, J.; Cin, P. D.; Antonescu, C. R.; Singer, S.; Hameed, M.; more...
Genes Chromosomes and Cancer (2012)

Fulltext@MSK | Save

CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers

Journal Article

Chen, J.; Guo, T.; Zhang, L.; Qin, L. X.; Singer, S.; Maki, R. G.; Taguchi, T.; DeMatteo, R.; Besmer, P.; Antonescu, C. R.
Genes Chromosomes and Cancer (2012)

Fulltext@MSK | Save

Sarcomas

Book Section

Singer, S.; Nielsen, T.; Antonescu, C. R.
In DeVita, V. T. Jr; Lawrence, T. S.; Rosenberg, S. A. (Eds.) Cancer: Principles & Practice of Oncology: Primer of the Molecular Biology of Cancer. 1st ed (2011)

Fulltext@MSK | Save

Sorafenib (SOR) in patients (pts) with imatinib (IM) and sunitinib (SU)-resistant (RES) gastrointestinal stromal tumors (GIST): Final results of a University of Chicago Phase II Consortium trial

Meeting Abstract

Kindler, H. L.; Campbell, N. P.; Wroblewski, K.; Maki, R. G.; D'Adamo, D. R.; Chow, W. A.; Gandara, D. R.; Antonescu, C.; Stadler, W. M.; Vokes, E. E.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Patterns of care, prognosis, and survival of patients with metastatic gastrointestinal stromal tumors (GIST) refractory to first-line imatinib and second-line sunitinib

Meeting Abstract

Italiano, A.; Cioffi, A.; Maki, R. G.; Schoffski, P.; Rutkowski, P.; Le Cesne, A.; Duffaud, F.; Adenis, A.; Isambert, N.; Bompas, E.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Metastatic epitheloid hemangioendothelioma (EHE): Role of systemic therapy and survival

Meeting Abstract

Cioffi, A.; Italiano, A.; Penel, N.; Berge, Y.; Toulmonde, M.; Salas, S.; Chevreau, C.; Le Cesne, A.; Duffaud, F.; D'Adamo, D. R.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

A phase II trial of sorafenib (S) and dacarbazine (D) in leiomyosarcoma (LMS), synovial sarcoma (SS), and malignant peripheral nerve sheath tumor (MPNST)

Meeting Abstract

D'Adamo, D. R.; Keohan, M. L.; Carvajal, R. D.; Hensley, M. L.; Hirst, C.; Qin, L.; Antonescu, C.; Lefkowitz, R. A.; Schwartz, G. K.; Maki, R. G.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Final results of a University of Chicago phase II consortium trial of sorafenib (SOR) in patients (pts) with imatinib (IM)- and sunitinib (SU)-resistant (RES) gastrointestinal stromal tumors (GIST)